Androski Lindsay bought ELOX
January 24, 2024 · Form 4 insider transaction
Androski Lindsay bought 7,500 shares of Eloxx Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
7,500
Price
$0.00
Total value
N/A
InsiderAndroski Lindsay
Role—
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateJanuary 24, 2024
Filing dateJanuary 26, 2024
Shares owned after7,500
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.; The RSUs vest as to 50% on the first anniversary of January 24, 2024 and, as to the remaining amount, in two equal annual installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date.